Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Minerva Urologica e Nefrologica 2017 October;69(5) > Minerva Urologica e Nefrologica 2017 October;69(5):475-85



Opzioni di pubblicazione
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca


Publication history
Per citare questo articolo


ORIGINAL ARTICLE   Free accessfree

Minerva Urologica e Nefrologica 2017 October;69(5):475-85

DOI: 10.23736/S0393-2249.17.02838-7


lingua: Inglese

Extended versus standard pelvic lymphadenectomy during robot-assisted radical prostatectomy: the role of extended template as an independent predictor of lymph node invasion with comparable morbidity burden

Francesco A. MISTRETTA 1 , Luca BOERI 1, Angelica A. GRASSO 1, Vito LO RUSSO 1, Giancarlo ALBO 1, Elisa DE LORENZIS 1, Marco MAGGIONI 2, Franco PALMISANO 1, Paolo DELL’ORTO 1, Silvano BOSARI 2, Bernardo ROCCO 1

1 Department of Urology, University of Milan, IRCCS Ca’ Granda, Ospedale Maggiore Policlinico Foundation, Milan, Italy; 2 Department of Pathology, University of Milan, IRCCS Ca’ Granda, Ospedale Maggiore Policlinico Foundation, Milan, Italy


BACKGROUND: To assess oncologic and surgical outcomes in patients subjected to standard (S) versus extended (E) pelvic lymph node dissection (PLND) during robot-assisted radical prostatectomy (RARP).
METHODS: From February 2009 to December 2015 a total of 184 consecutive patients underwent RARP and either standard or extended PLND for localized prostate cancer (PCa). Descriptive statistics compared clinical and pathological variables between groups. Logistic regression identified potential predictors of lymph node invasion (LNI).
RESULTS: No significant preoperative differences were found between the EPLND and SPLND groups. No difference in complication rates was observed between groups. No group differences were found for intraoperative blood loss, hospitalization times, positive surgical margins, biochemical recurrence, sexual dysfunction or need for adjuvant therapy. A higher median range of LN yield was found for the EPLND compared to SPLND cohort (22.5 vs. 12.8; P<0.001). Of the 36 patients who had positive LNs at the final pathology, 22 were in the EPLND group and 14 in the SPLND group (P<0.01). PSA, clinical stage and both number of nodes removed and EPLND were significant univariable predictors for LNI. In the multivariable model, PSA, clinical stage and number of removed nodes were independent predictors of LNI. EPLND was an independent predictor of LNI after accounting for PSA, clinical stage and Gleason Score stage.
CONCLUSIONS: EPLND during RARP is safe and effective. It results in more removed nodes and a higher LN positivity rate compared to SPLND, predicting LNI without increasing complications.

KEY WORDS: Prostatic neoplasms - Lymph node excision - Prostatectomy - Robotic surgical procedures

inizio pagina